For gut microbiome support, the named strain usually matters more than the raw CFU count: a documented strain like Lactobacillus rhamnosus GG has evidence tied to that exact organism, while a high CFU number of unnamed species tells you little about what it does. Xymogen ProbioMax and Metagenics UltraFlora both publish strain identities and guaranteed viability through expiration, so the real decision is matching specific strains to a patient's goal — not chasing the biggest billions-on-the-label figure.
CFU vs Strain, at a Glance
- CFU counts colony-forming units — quantity, not identity or function
- Strain specificity names the exact organism tied to the evidence
- A documented strain at a modest CFU often beats a huge unnamed dose
- Guaranteed viability through expiration matters more than at-manufacture counts
- ProbioMax and Metagenics both publish strains and guaranteed potency
- Match strains to the goal: regularity, immune, or post-antibiotic support
- Shelf-stable versus refrigerated affects dispensing and patient adherence
The number on the front of the bottle is the wrong headline
Patients and practitioners both get anchored on CFU count — the “50 billion” stamped across the label — because it is the easiest thing to compare. But CFU is a measure of quantity, not identity or effect. It tells you how many live organisms are in a serving; it tells you nothing about which organisms they are or what they have been shown to support. The more useful question is which strains are in the bottle and whether those specific strains match your patient's goal.
This is where a professional line earns its keep. Xymogen ProbioMax and Metagenics both name their strains down to the strain designation and guarantee potency through the expiration date, which lets you actually reason about the product instead of the marketing.
What CFU count really tells you
CFU — colony-forming units — is a viability count: how many organisms can grow into colonies under lab conditions. A higher number means a bigger dose, and dose does matter for some uses, such as post-antibiotic support where larger counts are common. But CFU is silent on species and strain. Ten billion of a well-documented strain can be more clinically meaningful than a hundred billion of an unnamed blend, because the evidence base attaches to specific organisms, not to the raw total.
The other CFU trap is timing. A count measured “at time of manufacture” can decay long before a patient swallows the capsule. What you want is a count guaranteed through expiration, which is what quality professional lines publish. Anything less means the front-of-bottle number is aspirational.
There is also a ceiling to how useful more CFU is. Beyond the dose a given goal calls for, additional billions do not linearly add benefit — they mostly add cost and, for some patients, more transient gas and bloating in the first week. That is the opposite of what most people assume when they reach for the biggest number on the shelf. A thoughtful practitioner treats CFU like any other dose: enough to do the job for the chosen strain, titrated to tolerance, and no higher for its own sake.
Why strain specificity usually wins
Probiotic evidence is strain-specific. Lactobacillus rhamnosus GG, Bifidobacterium lactis HN019, Saccharomyces boulardii — the research is tied to those exact strains, and you cannot assume a different strain of the same species behaves the same way. That is why a named strain is worth more than a bigger anonymous number: it lets you connect the product to what that organism has traditionally been used to support.
Both Xymogen ProbioMax and Metagenics UltraFlora identify strains explicitly. That means you can choose a product because it contains the strain matched to your goal, rather than because it has the largest headline count. When you are documenting why you selected a given probiotic for a patient, that strain-level reasoning is exactly the kind of detail that belongs in the chart — the same discipline covered in charting for integrative practices.
Strain naming also protects you from a subtle formulary problem: silent reformulation. When a product lists only species, a manufacturer can change the underlying strain without the label looking any different to you, and the “same” bottle quietly stops behaving the way it did. A named strain with a designation and, ideally, a deposited culture reference is a contract you can hold the product to. That is why professional lines that publish strain identities are worth the premium over consumer blends that hide behind a big species-level CFU figure.
Viability and shelf stability, the quiet deciders
A probiotic only works if the organisms are alive at the moment of ingestion. Two factors govern that: guaranteed potency through expiration, and shelf stability. Some Xymogen ProbioMax and Metagenics products are formulated to be shelf-stable at room temperature; others are best refrigerated. That distinction is not academic — it changes how you dispense and how well patients comply. A refrigerated probiotic left in a hot car loses viability, and a patient who has to remember the fridge is a patient more likely to miss doses.
For a practice that stocks and sells probiotics, shelf-stable SKUs are also simpler to hold and ship, which feeds straight into supplement inventory management. If a strain you want only comes refrigerated, plan the cold chain before you dispense it, not after.
Matching strains to the patient's goal
The practical workflow is goal-first, then strain, then dose, then format. For everyday regularity and general balance, a documented Lactobacillus and Bifidobacterium blend at a moderate CFU is usually plenty. For post-antibiotic support, clinicians often reach for higher counts and specific strains such as Saccharomyces boulardii. For immune-leaning goals, particular Bifidobacterium strains are commonly chosen. The CFU number rides along as a dose lever once the strain is set — it is the last decision, not the first.
Building that goal-to-strain logic the same way every time is exactly what protocol tooling is for; the reasoning mirrors what goes into building evidence-based supplement protocols, where the named ingredient and its rationale travel together into the plan.
Format is the last mile and it quietly drives adherence. Capsules, chewables, powders, and multi-strain versus single-strain products all change how likely a patient is to stay on the plan. A powder stirred into a morning routine may outperform a capsule the patient forgets in a cabinet, and a once-daily product beats a three-times-daily one for most people simply because fewer doses get missed. When you match strain to goal, do not stop at the organism — pick the format the patient in front of you will actually keep taking, and record why, so a colleague covering the case is not left guessing.
One compliance note worth stating plainly: none of this is a diagnosis or a treatment for disease, and it is general guidance rather than advice for any individual patient. Which strains and doses are appropriate depends on the person, and scope-of-practice rules for recommending or dispensing supplements vary by state and change over time. Verify your own scope with your state board or licensing body, and treat product selection as a clinical judgment made with the patient in front of you.
A functional-medicine clinician in Oregon stops chasing billions
A functional-medicine clinician in Oregon kept reordering whichever probiotic had the highest CFU count on the label, then wondered why results were inconsistent. When she audited her shelf, she realized she was rotating between products with completely different — and sometimes undisclosed — strains, so “the same probiotic” meant nothing.
She rebuilt her formulary around two decisions: a documented daily blend from one professional line for general support, and a specific Saccharomyces boulardii product for post-antibiotic use. She recorded the strain rationale for each patient in Supplement Practice so any provider in the clinic could see why a given product was chosen, not just that it was. Reorders got simpler and her post-antibiotic outcomes got more consistent.
| Factor | CFU Count | Strain Specificity |
|---|---|---|
| What it measures | Quantity of live organisms per serving | Identity of the exact organism |
| Ties to evidence? | No — number alone says nothing about function | Yes — research is strain-specific |
| When it matters most | Post-antibiotic and high-dose goals | Almost always — it is the first decision |
| Easy to game on a label? | Yes, especially “at manufacture” counts | No — named strains are verifiable |
| Both ProbioMax & Metagenics disclose it? | Yes, guaranteed through expiration | Yes, to the strain designation |
| Decide it | Last, as a dose lever | First, from the patient's goal |
Common mistakes when choosing a probiotic
- Buying on CFU alone. A huge unnamed count tells you nothing about what the product supports; the strain does.
- Ignoring the guarantee window. An “at manufacture” count can decay before the patient takes it — look for potency guaranteed through expiration.
- Treating species as strains. Two products with the same species can contain different strains that behave differently; the strain designation matters.
- Overlooking the cold chain. Dispensing a refrigerated probiotic without planning storage undercuts viability and adherence.
- Rotating blindly. Swapping between whichever bottle is cheapest means you are never actually giving the same strain a fair trial.
Frequently asked questions
Is a higher CFU probiotic always better?
No. CFU counts quantity, not function, and a documented strain at a moderate CFU often supports a goal better than a huge count of unnamed organisms. Higher counts matter most for specific uses like post-antibiotic support. Match the strain to the goal first, then use CFU as a dose lever.
What does strain specificity mean on a probiotic label?
It means the organism is named down to the strain — for example Lactobacillus rhamnosus GG, not just “Lactobacillus.” Because probiotic evidence is strain-specific, that designation is what lets you connect the product to what it has traditionally been used to support. Both Xymogen ProbioMax and Metagenics disclose strains this way.
Do Xymogen ProbioMax and Metagenics probiotics need refrigeration?
It depends on the specific product. Both lines offer shelf-stable options and others that are best refrigerated, so check the individual label and plan storage accordingly. Shelf-stable SKUs are easier to dispense and fit more cleanly into clinic inventory management.
How do I match a probiotic strain to a patient goal?
Start with the goal, then pick the documented strain, then set the dose. General balance often calls for a Lactobacillus and Bifidobacterium blend at a moderate CFU; post-antibiotic support often uses Saccharomyces boulardii; immune goals often use specific Bifidobacterium strains. This is a practitioner decision, not medical advice for any individual.
Why does viability through expiration matter?
Because a probiotic only works if the organisms are alive when swallowed. A count measured at manufacture can decay well before the expiration date, so a potency guaranteed through expiration is the number you can actually rely on.
Where to go next
Continue with building evidence-based protocols, supplement inventory management, and charting for integrative practices.
